Malocclusion
Conditions
Interventions
Novel developed miniscrew (NDM) group: patients with implantation of NDM between the date of approval and March 2020. Duration of interventional study: During multi-bracket treatment (approximately 2
Sponsors
Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients will have been diagnosed with the application of miniscrew implants between the date of approval and March 2020.
Exclusion criteria
Exclusion criteria: ?Unmanageable severe systemic disease ?Unmanageable bleeding disorder, Uncooperative patients without motivation ?Drugs, alcohol, nicotine addiction patients, and dysfunction of treatment resistance for long time ?Xerostomia ?Opportunistic immunodeficiency and leukocyte dysfunction ?Diseases requiring a regular steroid ?Unmanageable endocrine disease ?Hypersensitivity to titanium/ titanium alloy ?Abnormal wound healing function ?Administered bisphosphonates ?Not in good general condition ?The implanted area has some problems such as inflammation, tumors, cysts, lesions, and trauma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stability of miniscrew implants (at 1-3 months after implantation) | — |
Secondary
| Measure | Time frame |
|---|---|
| The tightening torque and loosening torque of miniscrew implants (after implantation immediately) | — |
Countries
Japan
Contacts
Public ContactKeiichiro Watanabe
Tokushima University Graduate School Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences
Outcome results
None listed